14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

Trading levels for VYGR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 8.80 4.43 %
R2 8.68 2.98 %
R1 8.61 2.08 %
Current price: 8.43
Support S1 8.36 -0.82 %
S2 8.29 -1.71 %
S3 8.16 -3.16 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 9.44 11.98 %
R2 9.28 10.08 %
R1 9.09 7.83 %
Current price 8.43
Support S1 8.32 -1.30%
S2 7.57 -10.20%
S3 7.55 -10.44%

VYGR Predictions History

4 years ago
Marcy Mercedes predicted that VYGR for 2020-04-23 is going

Rank:

4 years ago
JS predicted that VYGR for 2020-02-03 is going $10.96 (-6.72%)

4 years ago
Christopher Notte [STUDENT] predicted that VYGR for 2020-02-03 is going

Rank:

5 years ago
GoldenNugget predicted that VYGR for 2019-05-07 is going $22.95 (-4.55%)

5 years ago
NameNotImportant predicted that VYGR for 2019-05-06 is going $21.97 (-2.40%)

5 years ago
GoldenNugget predicted that VYGR for 2019-05-06 is going $21.18 (-5.89%)

5 years ago
NameNotImportant predicted that VYGR for 2019-05-03 is going $22.13 (-1.69%)

5 years ago
NameNotImportant predicted that VYGR for 2019-04-22 is going $20.94 (9.18%)

Click to get the best stock tips daily for free!

About Voyager Therapeutics

Voyager Therapeutics Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyotrophic lateral sclerosis; VY-HTT01 for Huntington's disease; VY-FXN01 for Friedreich's ataxia; and Tau... VYGR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT